Clinical trial
Evaluation of Eflornithine on Facial and Forearm Skin
NCT00152048 · Allergan, Industry · Completed
Key facts
| NCT number | NCT00152048 |
|---|---|
| Title | Evaluation of Eflornithine on Facial and Forearm Skin |
| Official title | A 24 Week Randomised Double Blind Placebo Controlled Study to Evaluate the Atrophogenic Potential of Eflornithine in the Treatment of Women With Excessive Facial Hair |
| Lead sponsor | Allergan, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hirsutism |
| Intervention type | Drug |
| Interventions | Eflornithine hydrochloride |
| Enrollment | 78 |
| Start date | Nov 30, 2004 |
| Completion | Oct 31, 2005 |
| First posted | Sep 9, 2005 |
| Last update posted | Oct 30, 2019 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: